NCT05177393 Treatment Outcomes of Esophageal Cancer
| NCT ID | NCT05177393 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of California, San Francisco |
| Condition | Esophageal Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,476 participants |
| Start Date | 2019-02-28 |
| Primary Completion | 2027-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,476 participants in total. It began in 2019-02-28 with a primary completion date of 2027-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will be a carried out through a prospective observational cohort design in conjunction with researchers in the African Esophageal Cancer Consortium (AfrECC). The purpose of this research is to prospectively evaluate outcomes related to existing treatment strategies for esophageal cancer (EC) at participating sites within AfrECC.
Eligibility Criteria
Inclusion Criteria: * Participants with histopathologically confirmed or presumptive clinical diagnosis of EC. For patients who do not have histopathologically confirmed disease, presumptive clinical diagnosis may be based upon barium swallow or endoscopy without biopsy. * Age 18 years of age or older; Exclusion Criteria: * Unable to provide informed consent
Contact & Investigator
Geoffrey Buckle, MD, MPH
PRINCIPAL INVESTIGATOR
University of California, San Francisco
Frequently Asked Questions
Who can join the NCT05177393 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Esophageal Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05177393 currently recruiting?
Yes, NCT05177393 is actively recruiting participants. Contact the research team at geoffrey.buckle@ucsf.edu for enrollment information.
Where is the NCT05177393 trial being conducted?
This trial is being conducted at Bomet, Kenya, Eldoret, Kenya, Lilongwe, Malawi, Dar es Salaam, Tanzania and 2 additional locations.
Who is sponsoring the NCT05177393 clinical trial?
NCT05177393 is sponsored by University of California, San Francisco. The principal investigator is Geoffrey Buckle, MD, MPH at University of California, San Francisco. The trial plans to enroll 2,476 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.